ML20141J089
| ML20141J089 | |
| Person / Time | |
|---|---|
| Issue date: | 07/20/1995 |
| From: | Siegel B NRC |
| To: | Stewart Schneider NRC |
| Shared Package | |
| ML20007J296 | List:
|
| References | |
| FRN-62FR4120, RULE-PR-20, RULE-PR-35 AE41-2-019, AE41-2-19, NUDOCS 9708140379 | |
| Download: ML20141J089 (4) | |
Text
_
I
%k l
l
~#E-6//-L From: *Barry Siegel" ("SIEGELB9MIRLINK.WUSTL.EDU")
l-To: sxs49nrc. gov Date: Thursday, July 20, 1995 3:30 pm
Subject:
Patient Release Criteria (SMTPId#: 43078)
Stewart: Any follow-up on the status of this evolving rule?
BAS I
i l
l l
4 l
1 J
i 97 140379 970807 P PR
_ W R4120 .PDR g
_ qq cff IQo~$ 9 9 - ott
F9E- r/)~- D._
{ ]iOHM M6 U.S. NUCLEAR REGULATORY COMMISSION ~ DA1E 7 7 23 %~
TELECOPIER TRANSMITTAL 11ME
\ oW l
WARNING: Most facsimile machines produce copies on thermal paper. The image produced is highly u nstable and will deteriorate significantly in a few years. Reproduce copies onto plain paper prior to filing as a record.
TO NAME 1ELEPHONE y , BenP/ $159E' 3N-lbMb4 NAME AND LOCAllON OF COMPANY (if other thatt NRC) mh Lv NC K11c0T Q rrrsiit OP (2ADICU)y
$rf LD6 LS. ; MO -
TELECOPY NUMDLR VERifiCAllON NUMBER 3 14 - 3tiz ct4 FROM NAM TELEPHONE MAIL STOP O b M fVT[ ljt 4 l(f d M Ib b3N TELECOPY DATA
_ NUMBER OF PAGES PRIORITY IMMEDIATE THIS PAGE + PAGES = TOTAL OTHER (Specify)
SPECIAL INSTRUCTIONS n p An, m/ - J -
Os
? \p O s, e 1 0.Vt e f j Q {(Tf$ [ \NOldt /j O c Tu\e. ic M M Ogg 3 9gg.
p us k 4f' / A (O M $
- ,Q g O( e - W C^' \ b 1 kW TCN4 AT
~~~'
PROBLEMS DISPOSITION OF ORIGINAL If any problems occur or if you do not receive all the pages, calt After telecopy has been sont, process the original as requested below. (Wnone are checked, the odginal wid be discatdad.)
RETURN TO SENDER HONE CALL AND SEh DER WILL PICK UP DISCARD YOC'6SSED BY (INITIALS) VERIFIED BY (INITIALS) t#4C F0FW 3aa {12 e2) P5WTLD ON HECYCLED PAPER
l O 35 .75 Criteria for-release of individuals containing radiopharmaceuticals or permanent implants.
(a) The licensee may release from its control any individual who has been administered radiopharmaceuticals or permanent implants containing radioactive material if the TEDE to any other individual from exposure to the-released individual is not likely to exceed 5 millisieverts (0.5 rem).
[b) The licensee shall provide the released individual with instructions, sncluding written instructions, on actions recommended to maintain doses to other individuals ALARA if the TEDE to any other individual is likely to exceed 1 millisievert (0.1 rem). If the released individual may be breast-feeding an infant or child, the instructions shall also include (1 guidance on the interruption of breast-feeding and (ii) information on the c)onsequences of failing to follow the guidance.
1 (c) The licensee shall maintain a record of the basis for authorizing the release of an individual for 3 years if: gg (1) The TEDE to the maximally exposed indivi al is calculated using an occupancy factor other than 0.25 at 1 meter, the biological or effective half-life,' or%a fector ss, %that considers the shielding by tissue.
(2) The TEDE to a breast-fed infant or child is likely to exceed 500 mrem assuming no interruption of breast-feeding.
O REVISED 7-27-95 G:\35 RULE.CHX
TRANSHISSION REPORT 07.27.1995 13:57 NRC-RESD$R/RPHED DATE 11ML (> U R 41 ] O N kEMOTE ID MODE PAG'S kESULT et.27 13e55 01'34" 13143622806 63 2 0.K.
l l
l l
l b
("
_